LTR Pharma LimitedASX: LTP

Quarterly Activities/Appendix 4C Cash Flow Report

· Issued by LTR Pharma Limited via ASX

Filed with ASX ·

On 6ix: 6ix.com/news/quarterly-activitiesappendix-4c-cash-flow-report-797

1800 519 711 | ltrpharma.com | info@ltrpharma.com LTR Pharma Limited (ABN 64 644 924 569 / ACN 644 924 569) 28 July 2026 Quarterly Activities Report & Appendix 4C For the Period Ending 30 June 2026 LTR Advances Toward U.S. Commercial Launch Following Key Clinical and ...

View Attachment

6ix hasn’t read this filing yet.

LTR Pharma Limited on 6ix

Earlier from LTR Pharma

Later from LTR Pharma

All LTR Pharma news releases